CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale General Counsel sold 9,232 shares at $9.31 ($85,921)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale General Counsel sold 9,232 shares at an average $8.37 ($77,256)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Open-market sale General Counsel sold 67,927 shares at an average $6.83 ($463,935)
- 4 Open-market sale General Counsel sold 26,381 shares at an average $6.08 ($160,457)
- 4 Open-market sale General Counsel sold 27,306 shares at an average $6.44 ($175,878)
- 4 Open-market sale General Counsel sold 47,287 shares at an average $6.26 ($295,985)
- 4 Option exercise Chief Financial Officer acquired 9,000 shares (option exercise)
- 4 Open-market buy Director bought 138,000 shares at $7.21 ($994,980)
- 4 Open-market buy Director bought 138,000 shares at $7.21 ($994,980)
Page 16 of 22 · 423 filings